Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−1.02 USD
−184.35 M USD
303.91 M USD
38.73 M
About AngioDynamics, Inc.
Sector
Industry
CEO
James Christopher Clemmer
Website
Headquarters
Latham
Founded
1988
FIGI
BBG000BB5621
AngioDynamics, Inc. is a medical device company, which engages in the development, manufacturing, and sale of medical devices for vascular access, surgery, peripheral vascular disease, and oncology. It offers ablation systems, fluid management systems, vascular access, angiographic, drainage, thrombolytic, and venous products. It operates through the Med Tech and Med Device segments. The company was founded by Howard S. Stern and Eamonn P. Hobbs on February 9, 1988 and is headquartered in Latham, NY.
AngioDynamics Buy TF D1 TP = 12.37On the daily chart, the trend started on May 1 (linear regression channel).
There is a high probability of profit. Possible take profit level is 12.37
But do not forget about the SL = 8.07
Using a trailing stop is also a good idea!
Please leave your feedback, your opinion. I am very intereste
Moving Average/Support/Resistance ExampleHere's a great example on how you can use a moving average to watch for trend reversals and to trigger trades in case you don't like drawing a lot of lines on your chart.
In this example, when the 50 Moving Average (MA) crossed the 200MA in May 2019, it signaled a bearish reversal (known as a beari
Interday Short- Great ReversalShorting ANGO 3/4/2019
Entry: 23.24$ at 15:53 NY Time.
Stop Size: 0.19$
Result: R/R 1:2
Trade Idea:
Interday Reversal strategy (Powerful stock in the interday, "Healthy"
Fibonacci Retracement, Price Retracing to a resistance level, Candlestick pattern Trigger).
Tools: VWAP, EMA20, Pivot Points.
ANOG: Small/Medium CFO/CEO- If They Buy, Might Want To Buy??Published on July 24, 2017 at 2:32 pm by TIM FREDERICK in Insider Trading,Market Movers,News
Two insiders at AngioDynamics, Inc. (NASDAQ:ANOG), including President and CEO James C. Clemmer, have bought shares of the company in the past week following a bout of weakness. Mr. Clemmer purchased 25,000
See all ideas
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Curated watchlists where ANGO is featured.

Mid-weight oncology stocks: The dark horses of cancer research
18 No. of Symbols
See all sparks
Related stocks
Frequently Asked Questions
The current price of ANGO is 9.60 USD — it has decreased by −0.41% in the past 24 hours. Watch AngioDynamics, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange AngioDynamics, Inc. stocks are traded under the ticker ANGO.
ANGO stock has risen by 2.89% compared to the previous week, the month change is a −5.33% fall, over the last year AngioDynamics, Inc. has showed a 65.52% increase.
We've gathered analysts' opinions on AngioDynamics, Inc. future price: according to them, ANGO price has a max estimate of 16.00 USD and a min estimate of 15.00 USD. Watch ANGO chart and read a more detailed AngioDynamics, Inc. stock forecast: see what analysts think of AngioDynamics, Inc. and suggest that you do with its stocks.
ANGO reached its all-time high on Nov 5, 2021 with the price of 32.00 USD, and its all-time low was 5.26 USD and was reached on Mar 25, 2024. View more price dynamics on ANGO chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
ANGO stock is 2.64% volatile and has beta coefficient of −0.032. Track AngioDynamics, Inc. stock price on the chart and check out the list of the most volatile stocks — is AngioDynamics, Inc. there?
Today AngioDynamics, Inc. has the market capitalization of 389.83 M, it has increased by 2.48% over the last week.
Yes, you can track AngioDynamics, Inc. financials in yearly and quarterly reports right on TradingView.
AngioDynamics, Inc. is going to release the next earnings report on Jul 9, 2025. Keep track of upcoming events with our Earnings Calendar.
ANGO earnings for the last quarter are −0.08 USD per share, whereas the estimation was −0.13 USD resulting in a 38.46% surprise. The estimated earnings for the next quarter are −0.12 USD per share. See more details about AngioDynamics, Inc. earnings.
AngioDynamics, Inc. revenue for the last quarter amounts to 72.01 M USD, despite the estimated figure of 70.30 M USD. In the next quarter, revenue is expected to reach 74.26 M USD.
ANGO net income for the last quarter is −4.41 M USD, while the quarter before that showed −10.74 M USD of net income which accounts for 58.96% change. Track more AngioDynamics, Inc. financial stats to get the full picture.
No, ANGO doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Apr 26, 2025, the company has 748 employees. See our rating of the largest employees — is AngioDynamics, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. AngioDynamics, Inc. EBITDA is 550.00 K USD, and current EBITDA margin is −2.01%. See more stats in AngioDynamics, Inc. financial statements.
Like other stocks, ANGO shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade AngioDynamics, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So AngioDynamics, Inc. technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating AngioDynamics, Inc. stock shows the neutral signal. See more of AngioDynamics, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.